CAMBRIDGE, Mass., Dec. 22, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted CAMBRIDGE, Mass., Dec. 22, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted

Nuvalent to Present at the 44th Annual J.P. Morgan Healthcare Conference

2025/12/22 19:45
1 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

CAMBRIDGE, Mass., Dec. 22, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 9:00 a.m. PT in San Francisco. 

A live webcast will be available in the Investors section of the company’s website at www.nuvalent.com, and archived for 30 days following the presentation.

About Nuvalent
Nuvalent, Inc. (Nasdaq: NUVL) is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvalent-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302647193.html

SOURCE Nuvalent, Inc.

Market Opportunity
MASS Logo
MASS Price(MASS)
$0.0003416
$0.0003416$0.0003416
+1.21%
USD
MASS (MASS) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Why LYNO’s Presale Could Trigger the Next Wave of Crypto FOMO After SOL and PEPE

Why LYNO’s Presale Could Trigger the Next Wave of Crypto FOMO After SOL and PEPE

The post Why LYNO’s Presale Could Trigger the Next Wave of Crypto FOMO After SOL and PEPE appeared on BitcoinEthereumNews.com. Cryptocirca has never been bereft of hype cycles and fear of missing out (FOMO). The case of Solana (SOL) and Pepe (PEPE) is one of the brightest examples that early investments into the correct projects may yield the returns that are drifting. Today there is an emerging rival in the limelight—LYNO. LYNO is in its presale stage, and already it is being compared to former breakout tokens, as many investors are speculating that LYNO will be the next big thing to ignite the market in a similar manner. Early Bird Presale: Lowest Price LYNO is in the Early Bird presale and costs only $0.050 for each token; the initial round will rise to $0.055. To date, approximately 629,165.744 tokens have been sold, with approximately $31,458.287 of that amount going towards the $100,000 project goal.  The crypto presales allow investors the privilege to acquire tokens at reduced prices before they become available to the general market, and they tend to bring substantial returns in the case of great fundamentals. The final goal of the project: 0.100 per token. This gradual development underscores increasing investor confidence and it brings a sense of urgency to those who wish to be first movers. LYNO’s Edge in a Competitive Market LYNO isn’t just another presale token—it’s a powerful AI-driven cross-chain arbitrage platform designed to deliver real utility and long-term growth. Operating across 15+ blockchains, LYNO’s AI engine analyzes token prices, liquidity, volume, and gas fees in real-time to identify the most profitable trade routes. It integrates with bridges like LayerZero, Wormhole, and Axelar, allowing assets to move instantly across networks, so no opportunity is missed.  The platform also includes community governance, letting $LYNO holders vote on protocol upgrades and fee structures, staking rewards for long-term investors, buyback-and-burn mechanisms to support token value, and audited smart…
Share
BitcoinEthereumNews2025/09/18 16:11
The $55 Oil Trade Is Still on the Table, but Brent’s Chart Has Conditions

The $55 Oil Trade Is Still on the Table, but Brent’s Chart Has Conditions

The post The $55 Oil Trade Is Still on the Table, but Brent’s Chart Has Conditions appeared on BitcoinEthereumNews.com. The oil price surged on April 2 as Brent
Share
BitcoinEthereumNews2026/04/02 18:30
Covéa Chooses Shift Technology as Strategic Partner for Fraud and Risk Management

Covéa Chooses Shift Technology as Strategic Partner for Fraud and Risk Management

Covéa has selected Shift Technology as a long-term partner to support a consistent and shared view of risk from policy inception through to claims settlement The
Share
ffnews2026/04/02 07:00

Trade GOLD, Share 1,000,000 USDT

Trade GOLD, Share 1,000,000 USDTTrade GOLD, Share 1,000,000 USDT

0 fees, up to 1,000x leverage, deep liquidity